This website uses cookies to enhance the user experience.
MENTIS CURA AS

MENTIS CURA AS916 997 477

Research
Limited company
Gaustadalléen 21 0349 OSLO, Norge

MENTIS CURA AS

mentiscura - Mentis Cura
Mentis Cura is a privately held diagnostic company serving clinicians and pharmaceutical clients with state-of-the-art services and technology to improve and accelerate the differential diagnosis of CNS disorders.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
8 years
since Apr 11, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
6,479,836
1 share class
Total number of shareholders
79
15 companies, 64 persons

Financials

Total operating income 2022
6,193,677
NOK
Annual total result 2022
-19,493,951
NOK
Total equity 2022
-478,592
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member
6.45 %
indirectly

Others

NameRoleShares
K
KPMG AS
Auditor-
D
DELIB ØKONOMI AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
9.53 %
indirectly
Board Member
6.45 %
indirectly
-
5.46 %
indirectly
-
4.5 %
indirectly
-
4.5 %
indirectly
-
3.1 %
indirectly
-
3.1 %
indirectly
-
3.1 %
indirectly
-
3.1 %
indirectly
-
2.32 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
N
NORTH MURRAY AS
Ordinary shares
1,370,556
21.15 %
S
STRATEL AS
Ordinary shares
804,000
12.41 %
Ordinary shares
701,688
10.83 %
R
RONDANE HOLDING AS
Ordinary shares
678,000
10.46 %
A
ABELSNES INVEST AS
Ordinary shares
418,212
6.45 %
Ordinary shares
363,275
5.61 %
B
BITTEBORGEN AS
Ordinary shares
353,568
5.46 %
F
FRAX AS
Ordinary shares
170,609
2.63 %
Ordinary shares
161,778
2.5 %
Ordinary shares
142,390
2.2 %
Ordinary shares
108,852
1.68 %
S
SKARV INVEST AS
Ordinary shares
94,691
1.46 %
A
ARAT AS
Ordinary shares
79,208
1.22 %
Ordinary shares
77,779
1.2 %
S
STYRE & STELL AS
Ordinary shares
75,544
1.17 %
Ordinary shares
63,287
0.98 %
Ordinary shares
56,521
0.87 %
Ordinary shares
53,379
0.82 %
Ordinary shares
52,129
0.8 %
Ordinary shares
50,414
0.78 %
Ordinary shares
48,032
0.74 %
Ordinary shares
39,821
0.61 %
Ordinary shares
37,490
0.58 %
Ordinary shares
36,657
0.57 %
R
REINSBU AS
Ordinary shares
35,870
0.55 %
Ordinary shares
27,029
0.42 %
Ordinary shares
21,697
0.33 %
Ordinary shares
21,352
0.33 %
T
TRK GROUP AS
Ordinary shares
20,000
0.31 %
Ordinary shares
18,792
0.29 %
Ordinary shares
18,536
0.29 %
Ordinary shares
18,535
0.29 %
Ordinary shares
15,996
0.25 %
Ordinary shares
14,669
0.23 %
Ordinary shares
14,111
0.22 %
Ordinary shares
13,548
0.21 %
Ordinary shares
13,316
0.21 %
K
KIMEN AS
Ordinary shares
10,590
0.16 %
Ordinary shares
10,000
0.15 %
S
SAGSTUA INVEST AS
Ordinary shares
10,000
0.15 %
Ordinary shares
9,250
0.14 %
Ordinary shares
9,250
0.14 %
Ordinary shares
9,000
0.14 %
Ordinary shares
8,723
0.13 %
Ordinary shares
8,391
0.13 %
Ordinary shares
7,955
0.12 %
Ordinary shares
7,777
0.12 %
Ordinary shares
7,500
0.12 %
Ordinary shares
6,740
0.1 %
B
BODDCO AS
Ordinary shares
6,282
0.1 %
Ordinary shares
6,071
0.09 %
Ordinary shares
6,071
0.09 %
Ordinary shares
5,714
0.09 %
Ordinary shares
5,318
0.08 %
Ordinary shares
5,000
0.08 %
Ordinary shares
4,444
0.07 %
Ordinary shares
4,190
0.06 %
Ordinary shares
4,000
0.06 %
Ordinary shares
3,770
0.06 %
Ordinary shares
3,659
0.06 %
Ordinary shares
2,857
0.04 %
Ordinary shares
2,643
0.04 %
Ordinary shares
2,641
0.04 %
Ordinary shares
2,641
0.04 %
Ordinary shares
2,500
0.04 %
Ordinary shares
2,400
0.04 %
Ordinary shares
2,333
0.04 %
G
GAMBIT INVEST AS
Ordinary shares
2,000
0.03 %
Ordinary shares
2,000
0.03 %
Ordinary shares
1,334
0.02 %
Ordinary shares
1,333
0.02 %
Ordinary shares
1,000
0.02 %
Ordinary shares
1,000
0.02 %
Ordinary shares
571
< 0.01 %
Ordinary shares
571
< 0.01 %
Ordinary shares
390
< 0.01 %
Ordinary shares
336
< 0.01 %
Ordinary shares
250
< 0.01 %
Ordinary shares
10
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year2021
Total operating income
6,193,677
Annual Total Result
-19,493,951
Total assets
2,756,261
Total liabilities
3,234,854
Total equity
-478,592

P&L

Year2021
Total operating income
6,193,677
Total operating costs
13,627,348
Operating result
-7,433,671
Financial income/costs
-12,060,280
Profit before tax
-19,493,951
Total tax & extraordinary income/cost
0
Annual Total Result
-19,493,951

Balance overview

Year2021
Total fixed assets
45,243
Total current assets
2,711,019
Total assets
2,756,261
Short term debt
3,029,854
Long term debt
205,000
Total liabilities
3,234,854
Contributed capital
6,479,836
Retained earnings
-6,958,428
Total equity
-478,592
Total equity and liabilities
2,756,261

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology